Rationale for combination therapy and comparative overview SGLT2 inhibitors and GLP-1 receptor agonists provide cardiovascular benefit through distinct clinical profiles
As patients on GLP-1 receptor agonists undergo weight loss (or even weight gain), it is important to understand underlying changes in body composition, including visceral and subcutaneous fat volume, abdominal muscle bulk and quality, bone mineral density, and organ properties (e.g., liver volume and attenuation)," corresponding author Perry J
Before prescribing either semaglutide or tirzepatide, our providers run an 80+ biomarker panel that goes far beyond what a typical weight loss clinic orders
Understanding how to structure such protocols helps optimize outcomes
The practical synthesis: retatrutide is the most effective fat-loss compound in the incretin class, it loses lean mass in a normal class-typical ratio, and the amount of muscle you keep is mostly in your control through protein, lifting, and a reasonable rate of loss
If more than 4 days have passed, skip that dose and wait for your next regularly scheduled day to keep your rhythm consistent